141 related articles for article (PubMed ID: 8722313)
1. Absent inhibition of hepatitis B virus replication by azidothymidine in patients chronically coinfected by HIV-1 and HBV.
Gallian P; De Lamballerie X; Lehucher MP; Dhiver C; Ravaux I
New Microbiol; 1996 Apr; 19(2):167-9. PubMed ID: 8722313
[TBL] [Abstract][Full Text] [Related]
2. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
4. Lamivudine useful against hepatitis B-HIV co-infection.
Prescott LM
J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):34. PubMed ID: 11362610
[TBL] [Abstract][Full Text] [Related]
5. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
Sheldon J; Camino N; Rodés B; Bartholomeusz A; Kuiper M; Tacke F; Núñez M; Mauss S; Lutz T; Klausen G; Locarnini S; Soriano V
Antivir Ther; 2005; 10(6):727-34. PubMed ID: 16218172
[TBL] [Abstract][Full Text] [Related]
6. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
Benhamou Y; Bochet M; Thibault V; Di Martino V; Caumes E; Bricaire F; Opolon P; Katlama C; Poynard T
Hepatology; 1999 Nov; 30(5):1302-6. PubMed ID: 10534354
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
9. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
Pessôa MG; Gazzard B; Huang AK; Brandão-Mello CE; Cassetti I; Mendes-Corrêa MC; Soriano V; Phiri P; Hall A; Brett-Smith H
AIDS; 2008 Sep; 22(14):1779-87. PubMed ID: 18753861
[TBL] [Abstract][Full Text] [Related]
11. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
Audsley J; Arrifin N; Yuen LK; Ayres A; Crowe SM; Bartholomeusz A; Locarnini SA; Mijch A; Lewin SR; Sasadeusz J
HIV Med; 2009 Apr; 10(4):229-35. PubMed ID: 19178592
[TBL] [Abstract][Full Text] [Related]
12. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
Dore GJ; Cooper DA; Pozniak AL; DeJesus E; Zhong L; Miller MD; Lu B; Cheng AK; ;
J Infect Dis; 2004 Apr; 189(7):1185-92. PubMed ID: 15031786
[TBL] [Abstract][Full Text] [Related]
14. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.
Dore GJ; Cooper DA; Barrett C; Goh LE; Thakrar B; Atkins M
J Infect Dis; 1999 Sep; 180(3):607-13. PubMed ID: 10438346
[TBL] [Abstract][Full Text] [Related]
15. Absence of effect of zidovudine on replication of hepatitis B virus in patients with chronic HIV and HBV infection.
Marcellin P; Pialoux G; Girard PM; Boyer N; Martinot-Peignoux M; Loriot MA; Dazza MC; Benhamou JP
N Engl J Med; 1989 Dec; 321(25):1758. PubMed ID: 2594033
[No Abstract] [Full Text] [Related]
16. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
[TBL] [Abstract][Full Text] [Related]
17. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient.
Henke-Gendo C; Amini-Bavil-Olyaee S; Challapalli D; Trautwein C; Deppe H; Schulz TF; Heim A; Tacke F
J Infect Dis; 2008 Dec; 198(11):1620-4. PubMed ID: 18847320
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
Puoti M; Airoldi M; Bruno R; Zanini B; Spinetti A; Pezzoli C; Patroni A; Castelli F; Sacchi P; Filice G; Carosi G
AIDS Rev; 2002; 4(1):27-35. PubMed ID: 11998781
[TBL] [Abstract][Full Text] [Related]
20. The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients.
Gelinck LB; Claas EC; Kroon FP
J Hepatol; 2005 Aug; 43(2):360-1; author reply 361. PubMed ID: 15970350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
